Neuspera Medical Inc.
@neusperamedical
Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illnesses.
ID: 1436461734982664197
10-09-2021 22:52:09
42 Tweet
36 Takipçi
16 Takip Edilen
We are looking forward to hearing our CEO Steffen Hovard present at LSI - Life Science Intelligence™ #LSIUSA24 about Neuspera Medical’s progress in bringing a unique neuromodulation platform to market with its first application in overactive bladder. #Neuspera #OAB #urology #neuromodulation
Our CEO Steffen Hovard had the pleasure of presenting at #LSIUSA24 about the Neuspera System – the unique #neuromodulation platform we are bringing to the market. Thank you LSI - Life Science Intelligence™ for the opportunity! #OAB #urology #incontinence
Heading to San Antonio for Amer. Urol. Assn. #AUA2024 May 3-6? We’ll be there conducting market research and meeting w/physicians and industry partners. Email or DM us to set up a meeting! #OAB #urology #incontinence #neuromodulation
We’re encouraged by the recently announced new 2024 AUA/SUFU guideline and what it means for OAB patients. Our CMO Dr. Steven Siegel released a statement on how this update can potentially help more OAB patients find relief: bit.ly/44YZFDZ.
Honored to be among the 65 companies chosen for the 2024 MedTech Innovator Innovator Accelerator Cohort! bit.ly/3x3IIvA#Neuspe… #OAB #urology #neuromodulation
🚨 Don't miss the season 3 premiere of Neurotech Pub! Join Matt Angle, & leading experts Jacob Robinson from motif neurotech, Grayson Zulauf from Resonant Link, & Alexander Yeh from Neuspera Medical Inc. as they discuss developments in wireless power tech for implantable devices.
Our Founder and CTO Alex Yeh joined fellow neurotech industry leaders for a “stimulating” deep-dive conversation on the most recent episode of the Paradromics Inc. Neurotech Pub podcast! Check it out here: bit.ly/45RgZLr. #Neuspera #OAB #urology #neuromodulation #medtech
Announcing the closure of our $23M Series D round led by Vertex Ventures HC & Treo Ventures w/participation by Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures & another strategic investor prn.to/3zGngxv. #OAB #urology #neuromodulation
Neuspera Medical (#LSIAlumni) closed a $23M Series D funding round led by Vertex Ventures HC and Treo Ventures. Congratulations to LSI Alumni, Steffen Hovard and the entire Neuspera Medical Inc. team on this major milestone! We look forward to following along your journey. #Medtech
Thank you MassDevice for recognizing us as one of “7 neurotech companies to know.” Proud to be on this list of innovators w/an #OAB treatment designed to deliver ultimate symptom control. massdevice.com/7-neurotech-co… #urology #incontinence #neuromod
It’s been a great experience to be a part of the 2024 MedTech Innovator Innovator Accelerator Cohort! What’s the next exciting thing for Neuspera this year? We’re preparing to submit our PMA app to the FDA! bit.ly/3x3IIvA #Neuspera #OAB #urology #neuromodulation